ACM
BIIB icon

Americafirst Capital Management’s Biogen BIIB Stock Holding History

Americafirst Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$825K Buy
+2,636
New +$781K 1.11% 11
2016
Q4 		– Sell
-1,502
Closed -$470K – 199
2016
Q3 		$470K Sell
1,502
-6,512
-81% -$1.93M 0.39% 71
2016
Q2 		$1.94M Buy
8,014
+1,399
+21% +$369K 1.25% 28
2016
Q1 		$1.72M Buy
+6,615
New +$1.75M 1.08% 32

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Americafirst Capital Management's BIIB Position: Q3 2017 in Review

Americafirst Capital Management opened a new position in Biogen (BIIB) in Q3 2017: 2,636 shares worth $825K. The stake represents 1.11% of the portfolio and ranks #11 among its holdings. This is a return to the name: Americafirst Capital Management previously reported a position in BIIB as recently as Q3 2016.

Americafirst Capital Management first reported a position in BIIB in Q1 2016 and has held it in 4 quarters since. The position peaked at $1.94M in Q2 2016. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Americafirst Capital Management held 2,636 shares of Biogen worth $825K as of Q3 2017.
  • Biogen was a new Americafirst Capital Management position in Q3 2017.
  • Biogen made up 1.11% of Americafirst Capital Management's portfolio in Q3 2017, its #11 holding.
  • Americafirst Capital Management first reported a position in Biogen in Q1 2016 and has held it in 4 quarters since.
  • Americafirst Capital Management's Biogen position peaked at $1.94M in Q2 2016.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.